T&R Biofab Co. Ltd
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.
T&R Biofab Co. Ltd (246710) - Total Liabilities
Latest total liabilities as of September 2025: ₩72.55 Billion KRW
Based on the latest financial reports, T&R Biofab Co. Ltd (246710) has total liabilities worth ₩72.55 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
T&R Biofab Co. Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how T&R Biofab Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
T&R Biofab Co. Ltd Competitors by Total Liabilities
The table below lists competitors of T&R Biofab Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Indonesia Energy
NYSE MKT:INDO
|
USA | $3.28 Million |
|
SebitChem Co. Ltd.
KQ:107600
|
Korea | ₩37.03 Billion |
|
Pontex Polyblend Co.Ltd
TWO:8935
|
Taiwan | NT$523.62 Million |
|
Danen Technology Corp
TW:3686
|
Taiwan | NT$9.62 Million |
|
Alpha Pro Tech Ltd
NYSE MKT:APT
|
USA | $11.33 Million |
|
Lument Finance Trust Inc
NYSE:LFT
|
USA | $725.65 Million |
|
DP Aircraft I Limited
LSE:DPA
|
UK | $98.26 Million |
|
Omega Oil & Gas Ltd
AU:OMA
|
Australia | AU$2.83 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down T&R Biofab Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.87 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how T&R Biofab Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for T&R Biofab Co. Ltd (2015–2024)
The table below shows the annual total liabilities of T&R Biofab Co. Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩74.24 Billion | +8.19% |
| 2023-12-31 | ₩68.62 Billion | +87.10% |
| 2022-12-31 | ₩36.67 Billion | -9.54% |
| 2021-12-31 | ₩40.54 Billion | +1552.73% |
| 2020-12-31 | ₩2.45 Billion | +5.25% |
| 2019-12-31 | ₩2.33 Billion | +178.40% |
| 2018-12-31 | ₩837.09 Million | +111.68% |
| 2017-12-31 | ₩395.46 Million | -46.44% |
| 2016-12-31 | ₩738.36 Million | -60.60% |
| 2015-12-31 | ₩1.87 Billion | -- |